Vanda Pharmaceuticals Inc.
NASDAQ:VNDA
5.1 (USD) • At close September 13, 2024
Overzicht | Financiële gegevens
Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Omzet
| 192.64 | 254.382 | 268.682 | 248.168 | 227.188 | 193.118 | 165.083 | 146.017 | 109.925 | 50.157 | 33.879 | 32.727 | 31.27 | 35.22 | 4.548 | 0 | 0 | 0 | 0 | 0.034 |
| Kosten van de omzet
| 16.886 | 24.282 | 25.629 | 23.364 | 24.488 | 20.508 | 17.848 | 24.712 | 23.462 | 1.583 | 0 | 0.129 | 0 | 4.386 | 2.898 | 0 | 0 | 0 | 0 | 0 |
| Brutowinst
| 175.754 | 230.1 | 243.053 | 224.804 | 202.7 | 172.61 | 147.235 | 121.305 | 86.463 | 48.574 | 33.879 | 32.598 | 31.27 | 30.834 | 1.65 | 0 | 0 | 0 | 0 | 0.034 |
| Brutowinstmarge
| 0.912 | 0.905 | 0.905 | 0.906 | 0.892 | 0.894 | 0.892 | 0.831 | 0.787 | 0.968 | 1 | 0.996 | 1 | 0.875 | 0.363 | 0 | 0 | 0 | 0 | 1 |
| Onderzoek- en ontwikkelingskosten
| 76.823 | 85.77 | 75.363 | 55.577 | 48.649 | 43.594 | 38.547 | 29.156 | 29.145 | 19.23 | 28.19 | 45.446 | 28.996 | 12.338 | 13.874 | 23.936 | 47.235 | 52.071 | 16.891 | 7.443 |
| Algemene en administratieve kosten
| 112.383 | 133.885 | 117.347 | 127.91 | 126.536 | 105.751 | 123.841 | 99.787 | 84.531 | 84.644 | 24.594 | 13.882 | 11.486 | 10.147 | 23.724 | 28.91 | 32.804 | 13.638 | 0 | 0 |
| Verkoop- en marketingkosten
| 0.5 | 2.6 | 6.7 | 12.6 | 3.2 | 0.9 | 1.3 | 1.4 | 3.4 | 5 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Verkoop-, algemene en administratieve kosten
| 112.883 | 136.485 | 124.047 | 140.51 | 129.736 | 105.751 | 123.841 | 99.787 | 84.531 | 84.644 | 24.594 | 13.882 | 11.486 | 10.147 | 23.724 | 28.91 | 32.804 | 13.638 | 7.396 | 2.119 |
| Overige kosten
| 20.291 | 1.516 | 1.478 | 1.478 | 1.505 | 3.608 | 1.472 | 0.665 | 0.32 | 0.124 | 0.145 | 0.561 | 1.495 | 1.495 | 0 | 0 | 0 | 0 | 0 | 0 |
| Bedrijfskosten
| 189.706 | 223.771 | 200.888 | 197.565 | 179.89 | 150.872 | 164.138 | 139.876 | 126.648 | 106.128 | 54.279 | 60.823 | 41.977 | 22.485 | 37.598 | 52.845 | 80.038 | 65.708 | 24.287 | 9.562 |
| Bedrijfsresultaat
| -13.952 | 6.329 | 42.165 | 27.239 | 22.81 | 21.738 | -16.903 | -18.571 | -40.185 | 20.062 | -20.4 | -28.225 | -10.707 | 8.349 | -35.948 | -52.845 | -80.038 | -65.708 | -24.287 | -9.528 |
| Bedrijfsresultaat ratio
| -0.072 | 0.025 | 0.157 | 0.11 | 0.1 | 0.113 | -0.102 | -0.127 | -0.366 | 0.4 | -0.602 | -0.862 | -0.342 | 0.237 | -7.905 | 0 | 0 | 0 | 0 | -280.412 |
| Totaal overige inkomsten en kosten netto
| 20.291 | 4.971 | 0.199 | 4.416 | 6.218 | 3.608 | 1.472 | 0.665 | 0.32 | 77.74 | 0.145 | 0.561 | 0.461 | 0.489 | 0.089 | 1.781 | 0.071 | 2.198 | 0 | 0 |
| Inkomen voor belasting
| 6.339 | 11.3 | 42.364 | 31.655 | 29.028 | 25.346 | -15.431 | -17.906 | -39.865 | 20.186 | -20.255 | -27.664 | -10.246 | 9.269 | -35.859 | -51.064 | -74.06 | -63.511 | -23.877 | -9.469 |
| Inkomen voor belasting ratio
| 0.033 | 0.044 | 0.158 | 0.128 | 0.128 | 0.131 | -0.093 | -0.123 | -0.363 | 0.402 | -0.598 | -0.845 | -0.328 | 0.263 | -7.885 | 0 | 0 | 0 | 0 | -278.674 |
| Belastingkosten
| 3.83 | 5.025 | 9.212 | 8.318 | -86.525 | 0.138 | 0.136 | 0.104 | 0 | -77.616 | 0 | 0 | -0.444 | 2.077 | 0 | 1.781 | 0.01 | 0.001 | 0.008 | 0.005 |
| Nettowinst
| 2.509 | 6.275 | 33.152 | 23.337 | 115.553 | 25.208 | -15.567 | -18.01 | -39.865 | 20.186 | -20.255 | -27.664 | -9.802 | 7.192 | -35.859 | -51.064 | -74.07 | -63.511 | -23.884 | -9.474 |
| Nettowinstmarge
| 0.013 | 0.025 | 0.123 | 0.094 | 0.509 | 0.131 | -0.094 | -0.123 | -0.363 | 0.402 | -0.598 | -0.845 | -0.313 | 0.204 | -7.885 | 0 | 0 | 0 | 0 | -278.819 |
| WPA (Winst Per Aandeel)
| 0.044 | 0.11 | 0.6 | 0.43 | 2.17 | 0.5 | -0.35 | -0.41 | -0.94 | 0.58 | -0.67 | -0.98 | -0.35 | 0.26 | -1.33 | -1.92 | -2.81 | -3.97 | -1.09 | -0.02 |
| Verwaterde WPA
| 0.044 | 0.11 | 0.58 | 0.42 | 2.11 | 0.48 | -0.35 | -0.41 | -0.94 | 0.55 | -0.67 | -0.98 | -0.35 | 0.25 | -1.33 | -1.92 | -2.81 | -3.97 | -1.09 | -0.02 |
| EBITDA
| -10.942 | 7.845 | 43.643 | 30.103 | 24.315 | 23.265 | -15.153 | -7.638 | -27.213 | -132.916 | -18.905 | -26.73 | -9.673 | 9.691 | -34.523 | -50.533 | -79.538 | -65.133 | -23.863 | -9.152 |
| EBITDA ratio
| -0.057 | 0.031 | 0.162 | 0.121 | 0.107 | 0.12 | -0.092 | -0.052 | -0.248 | -2.65 | -0.558 | -0.817 | -0.309 | 0.275 | -7.591 | 0 | 0 | 0 | 0 | -269.332 |